Global Foot and Mouth Disease (FMD) Vaccines Market Growth 2023-2029

Foot and Mouth Disease (FMD) vaccines are vaccines that provide active acquired immunity to Foot and Mouth Disease (FMD). Foot and Mouth Disease (FMD) is a highly contagious viral disease that primarily affects cloven-hooved livestock and wildlife like cattle, pigs, sheep and goats.

LPI (LP Information)' newest research report, the “Foot and Mouth Disease (FMD) Vaccines Industry Forecast” looks at past sales and reviews total world Foot and Mouth Disease (FMD) Vaccines sales in 2022, providing a comprehensive analysis by region and market sector of projected Foot and Mouth Disease (FMD) Vaccines sales for 2023 through 2029. With Foot and Mouth Disease (FMD) Vaccines sales broken down by region, market sector and sub-sector, this report provides a detailed analysis in US$ millions of the world Foot and Mouth Disease (FMD) Vaccines industry.

This Insight Report provides a comprehensive analysis of the global Foot and Mouth Disease (FMD) Vaccines landscape and highlights key trends related to product segmentation, company formation, revenue, and market share, latest development, and M&A activity. This report also analyzes the strategies of leading global companies with a focus on Foot and Mouth Disease (FMD) Vaccines portfolios and capabilities, market entry strategies, market positions, and geographic footprints, to better understand these firms' unique position in an accelerating global Foot and Mouth Disease (FMD) Vaccines market.

This Insight Report evaluates the key market trends, drivers, and affecting factors shaping the global outlook for Foot and Mouth Disease (FMD) Vaccines and breaks down the forecast by type, by application, geography, and market size to highlight emerging pockets of opportunity. With a transparent methodology based on hundreds of bottom-up qualitative and quantitative market inputs, this study forecast offers a highly nuanced view of the current state and future trajectory in the global Foot and Mouth Disease (FMD) Vaccines.

The global Foot and Mouth Disease (FMD) Vaccines market size is projected to grow from US$ 1023.2 million in 2022 to US$ 1988.8 million in 2029; it is expected to grow at a CAGR of 1988.8 from 2023 to 2029.

Global Foot and Mouth Disease (FMD) Vaccines key players include Jinyu Group, Indian Immunologicals, Tecon Group, CAHIC, etc. Global top four manufacturers hold a share nearly 60%.

Asia-Pacific is the largest market, with a share about 80%, followed by Central & South America, and Europe, both have a share over 15 percent. 
In terms of product, Conventional Vaccines is the largest segment, with a share about 70%. And in terms of application, the largest application is Cattle, followed by Pig, Sheep and Goat , etc.

This report presents a comprehensive overview, market shares, and growth opportunities of Foot and Mouth Disease (FMD) Vaccines market by product type, application, key manufacturers and key regions and countries.

Market Segmentation:
Segmentation by type
    Emergency Vaccines
    Conventional Vaccines

Segmentation by application
    Cattle
    Pig
    Sheep and Goat
    Others

This report also splits the market by region:
    Americas
        United States
        Canada
        Mexico
        Brazil
    APAC
        China
        Japan
        Korea
        Southeast Asia
        India
        Australia
    Europe
        Germany
        France
        UK
        Italy
        Russia
    Middle East & Africa
        Egypt
        South Africa
        Israel
        Turkey
        GCC Countries

The below companies that are profiled have been selected based on inputs gathered from primary experts and analyzing the company's coverage, product portfolio, its market penetration.
    Jinyu Group
    Cavet Bio
    Indian Immunologicals
    Tecon Group
    CAHIC
    Shen Lian
    Biogenesis Bagó
    BIGVET Biotech
    Boehringer Ingelheim
    MSD Animal Health
    CEVA
    FGBI
    Bayer HealthCare
    Brilliant Bio Pharma
    VECOL
    Sanofi (Merial)
    VETAL
    BVI
    LIMOR
    ME VAC
    Agrovet

Key Questions Addressed in this Report
What is the 10-year outlook for the global Foot and Mouth Disease (FMD) Vaccines market?
What factors are driving Foot and Mouth Disease (FMD) Vaccines market growth, globally and by region?
Which technologies are poised for the fastest growth by market and region?
How do Foot and Mouth Disease (FMD) Vaccines market opportunities vary by end market size?
How does Foot and Mouth Disease (FMD) Vaccines break out type, application?
What are the influences of COVID-19 and Russia-Ukraine war?

List of Tables
    Table 1. Foot and Mouth Disease (FMD) Vaccines Annual Sales CAGR by Geographic Region (2018, 2022 & 2029) & ($ millions)
    Table 2. Foot and Mouth Disease (FMD) Vaccines Annual Sales CAGR by Country/Region (2018, 2022 & 2029) & ($ millions)
    Table 3. Major Players of Emergency Vaccines
    Table 4. Major Players of Conventional Vaccines
    Table 5. Global Foot and Mouth Disease (FMD) Vaccines Sales by Type (2018-2023) & (M Doses)
    Table 6. Global Foot and Mouth Disease (FMD) Vaccines Sales Market Share by Type (2018-2023)
    Table 7. Global Foot and Mouth Disease (FMD) Vaccines Revenue by Type (2018-2023) & ($ million)
    Table 8. Global Foot and Mouth Disease (FMD) Vaccines Revenue Market Share by Type (2018-2023)
    Table 9. Global Foot and Mouth Disease (FMD) Vaccines Sale Price by Type (2018-2023) & (USD/K Doses)
    Table 10. Global Foot and Mouth Disease (FMD) Vaccines Sales by Application (2018-2023) & (M Doses)
    Table 11. Global Foot and Mouth Disease (FMD) Vaccines Sales Market Share by Application (2018-2023)
    Table 12. Global Foot and Mouth Disease (FMD) Vaccines Revenue by Application (2018-2023)
    Table 13. Global Foot and Mouth Disease (FMD) Vaccines Revenue Market Share by Application (2018-2023)
    Table 14. Global Foot and Mouth Disease (FMD) Vaccines Sale Price by Application (2018-2023) & (USD/K Doses)
    Table 15. Global Foot and Mouth Disease (FMD) Vaccines Sales by Company (2018-2023) & (M Doses)
    Table 16. Global Foot and Mouth Disease (FMD) Vaccines Sales Market Share by Company (2018-2023)
    Table 17. Global Foot and Mouth Disease (FMD) Vaccines Revenue by Company (2018-2023) ($ Millions)
    Table 18. Global Foot and Mouth Disease (FMD) Vaccines Revenue Market Share by Company (2018-2023)
    Table 19. Global Foot and Mouth Disease (FMD) Vaccines Sale Price by Company (2018-2023) & (USD/K Doses)
    Table 20. Key Manufacturers Foot and Mouth Disease (FMD) Vaccines Producing Area Distribution and Sales Area
    Table 21. Players Foot and Mouth Disease (FMD) Vaccines Products Offered
    Table 22. Foot and Mouth Disease (FMD) Vaccines Concentration Ratio (CR3, CR5 and CR10) & (2018-2023)
    Table 23. New Products and Potential Entrants
    Table 24. Mergers & Acquisitions, Expansion
    Table 25. Global Foot and Mouth Disease (FMD) Vaccines Sales by Geographic Region (2018-2023) & (M Doses)
    Table 26. Global Foot and Mouth Disease (FMD) Vaccines Sales Market Share Geographic Region (2018-2023)
    Table 27. Global Foot and Mouth Disease (FMD) Vaccines Revenue by Geographic Region (2018-2023) & ($ millions)
    Table 28. Global Foot and Mouth Disease (FMD) Vaccines Revenue Market Share by Geographic Region (2018-2023)
    Table 29. Global Foot and Mouth Disease (FMD) Vaccines Sales by Country/Region (2018-2023) & (M Doses)
    Table 30. Global Foot and Mouth Disease (FMD) Vaccines Sales Market Share by Country/Region (2018-2023)
    Table 31. Global Foot and Mouth Disease (FMD) Vaccines Revenue by Country/Region (2018-2023) & ($ millions)
    Table 32. Global Foot and Mouth Disease (FMD) Vaccines Revenue Market Share by Country/Region (2018-2023)
    Table 33. Americas Foot and Mouth Disease (FMD) Vaccines Sales by Country (2018-2023) & (M Doses)
    Table 34. Americas Foot and Mouth Disease (FMD) Vaccines Sales Market Share by Country (2018-2023)
    Table 35. Americas Foot and Mouth Disease (FMD) Vaccines Revenue by Country (2018-2023) & ($ Millions)
    Table 36. Americas Foot and Mouth Disease (FMD) Vaccines Revenue Market Share by Country (2018-2023)
    Table 37. Americas Foot and Mouth Disease (FMD) Vaccines Sales by Type (2018-2023) & (M Doses)
    Table 38. Americas Foot and Mouth Disease (FMD) Vaccines Sales by Application (2018-2023) & (M Doses)
    Table 39. APAC Foot and Mouth Disease (FMD) Vaccines Sales by Region (2018-2023) & (M Doses)
    Table 40. APAC Foot and Mouth Disease (FMD) Vaccines Sales Market Share by Region (2018-2023)
    Table 41. APAC Foot and Mouth Disease (FMD) Vaccines Revenue by Region (2018-2023) & ($ Millions)
    Table 42. APAC Foot and Mouth Disease (FMD) Vaccines Revenue Market Share by Region (2018-2023)
    Table 43. APAC Foot and Mouth Disease (FMD) Vaccines Sales by Type (2018-2023) & (M Doses)
    Table 44. APAC Foot and Mouth Disease (FMD) Vaccines Sales by Application (2018-2023) & (M Doses)
    Table 45. Europe Foot and Mouth Disease (FMD) Vaccines Sales by Country (2018-2023) & (M Doses)
    Table 46. Europe Foot and Mouth Disease (FMD) Vaccines Sales Market Share by Country (2018-2023)
    Table 47. Europe Foot and Mouth Disease (FMD) Vaccines Revenue by Country (2018-2023) & ($ Millions)
    Table 48. Europe Foot and Mouth Disease (FMD) Vaccines Revenue Market Share by Country (2018-2023)
    Table 49. Europe Foot and Mouth Disease (FMD) Vaccines Sales by Type (2018-2023) & (M Doses)
    Table 50. Europe Foot and Mouth Disease (FMD) Vaccines Sales by Application (2018-2023) & (M Doses)
    Table 51. Middle East & Africa Foot and Mouth Disease (FMD) Vaccines Sales by Country (2018-2023) & (M Doses)
    Table 52. Middle East & Africa Foot and Mouth Disease (FMD) Vaccines Sales Market Share by Country (2018-2023)
    Table 53. Middle East & Africa Foot and Mouth Disease (FMD) Vaccines Revenue by Country (2018-2023) & ($ Millions)
    Table 54. Middle East & Africa Foot and Mouth Disease (FMD) Vaccines Revenue Market Share by Country (2018-2023)
    Table 55. Middle East & Africa Foot and Mouth Disease (FMD) Vaccines Sales by Type (2018-2023) & (M Doses)
    Table 56. Middle East & Africa Foot and Mouth Disease (FMD) Vaccines Sales by Application (2018-2023) & (M Doses)
    Table 57. Key Market Drivers & Growth Opportunities of Foot and Mouth Disease (FMD) Vaccines
    Table 58. Key Market Challenges & Risks of Foot and Mouth Disease (FMD) Vaccines
    Table 59. Key Industry Trends of Foot and Mouth Disease (FMD) Vaccines
    Table 60. Foot and Mouth Disease (FMD) Vaccines Raw Material
    Table 61. Key Suppliers of Raw Materials
    Table 62. Foot and Mouth Disease (FMD) Vaccines Distributors List
    Table 63. Foot and Mouth Disease (FMD) Vaccines Customer List
    Table 64. Global Foot and Mouth Disease (FMD) Vaccines Sales Forecast by Region (2024-2029) & (M Doses)
    Table 65. Global Foot and Mouth Disease (FMD) Vaccines Revenue Forecast by Region (2024-2029) & ($ millions)
    Table 66. Americas Foot and Mouth Disease (FMD) Vaccines Sales Forecast by Country (2024-2029) & (M Doses)
    Table 67. Americas Foot and Mouth Disease (FMD) Vaccines Revenue Forecast by Country (2024-2029) & ($ millions)
    Table 68. APAC Foot and Mouth Disease (FMD) Vaccines Sales Forecast by Region (2024-2029) & (M Doses)
    Table 69. APAC Foot and Mouth Disease (FMD) Vaccines Revenue Forecast by Region (2024-2029) & ($ millions)
    Table 70. Europe Foot and Mouth Disease (FMD) Vaccines Sales Forecast by Country (2024-2029) & (M Doses)
    Table 71. Europe Foot and Mouth Disease (FMD) Vaccines Revenue Forecast by Country (2024-2029) & ($ millions)
    Table 72. Middle East & Africa Foot and Mouth Disease (FMD) Vaccines Sales Forecast by Country (2024-2029) & (M Doses)
    Table 73. Middle East & Africa Foot and Mouth Disease (FMD) Vaccines Revenue Forecast by Country (2024-2029) & ($ millions)
    Table 74. Global Foot and Mouth Disease (FMD) Vaccines Sales Forecast by Type (2024-2029) & (M Doses)
    Table 75. Global Foot and Mouth Disease (FMD) Vaccines Revenue Forecast by Type (2024-2029) & ($ Millions)
    Table 76. Global Foot and Mouth Disease (FMD) Vaccines Sales Forecast by Application (2024-2029) & (M Doses)
    Table 77. Global Foot and Mouth Disease (FMD) Vaccines Revenue Forecast by Application (2024-2029) & ($ Millions)
    Table 78. Jinyu Group Basic Information, Foot and Mouth Disease (FMD) Vaccines Manufacturing Base, Sales Area and Its Competitors
    Table 79. Jinyu Group Foot and Mouth Disease (FMD) Vaccines Product Portfolios and Specifications
    Table 80. Jinyu Group Foot and Mouth Disease (FMD) Vaccines Sales (M Doses), Revenue ($ Million), Price (USD/K Doses) and Gross Margin (2018-2023)
    Table 81. Jinyu Group Main Business
    Table 82. Jinyu Group Latest Developments
    Table 83. Cavet Bio Basic Information, Foot and Mouth Disease (FMD) Vaccines Manufacturing Base, Sales Area and Its Competitors
    Table 84. Cavet Bio Foot and Mouth Disease (FMD) Vaccines Product Portfolios and Specifications
    Table 85. Cavet Bio Foot and Mouth Disease (FMD) Vaccines Sales (M Doses), Revenue ($ Million), Price (USD/K Doses) and Gross Margin (2018-2023)
    Table 86. Cavet Bio Main Business
    Table 87. Cavet Bio Latest Developments
    Table 88. Indian Immunologicals Basic Information, Foot and Mouth Disease (FMD) Vaccines Manufacturing Base, Sales Area and Its Competitors
    Table 89. Indian Immunologicals Foot and Mouth Disease (FMD) Vaccines Product Portfolios and Specifications
    Table 90. Indian Immunologicals Foot and Mouth Disease (FMD) Vaccines Sales (M Doses), Revenue ($ Million), Price (USD/K Doses) and Gross Margin (2018-2023)
    Table 91. Indian Immunologicals Main Business
    Table 92. Indian Immunologicals Latest Developments
    Table 93. Tecon Group Basic Information, Foot and Mouth Disease (FMD) Vaccines Manufacturing Base, Sales Area and Its Competitors
    Table 94. Tecon Group Foot and Mouth Disease (FMD) Vaccines Product Portfolios and Specifications
    Table 95. Tecon Group Foot and Mouth Disease (FMD) Vaccines Sales (M Doses), Revenue ($ Million), Price (USD/K Doses) and Gross Margin (2018-2023)
    Table 96. Tecon Group Main Business
    Table 97. Tecon Group Latest Developments
    Table 98. CAHIC Basic Information, Foot and Mouth Disease (FMD) Vaccines Manufacturing Base, Sales Area and Its Competitors
    Table 99. CAHIC Foot and Mouth Disease (FMD) Vaccines Product Portfolios and Specifications
    Table 100. CAHIC Foot and Mouth Disease (FMD) Vaccines Sales (M Doses), Revenue ($ Million), Price (USD/K Doses) and Gross Margin (2018-2023)
    Table 101. CAHIC Main Business
    Table 102. CAHIC Latest Developments
    Table 103. Shen Lian Basic Information, Foot and Mouth Disease (FMD) Vaccines Manufacturing Base, Sales Area and Its Competitors
    Table 104. Shen Lian Foot and Mouth Disease (FMD) Vaccines Product Portfolios and Specifications
    Table 105. Shen Lian Foot and Mouth Disease (FMD) Vaccines Sales (M Doses), Revenue ($ Million), Price (USD/K Doses) and Gross Margin (2018-2023)
    Table 106. Shen Lian Main Business
    Table 107. Shen Lian Latest Developments
    Table 108. Biogenesis Bagó Basic Information, Foot and Mouth Disease (FMD) Vaccines Manufacturing Base, Sales Area and Its Competitors
    Table 109. Biogenesis Bagó Foot and Mouth Disease (FMD) Vaccines Product Portfolios and Specifications
    Table 110. Biogenesis Bagó Foot and Mouth Disease (FMD) Vaccines Sales (M Doses), Revenue ($ Million), Price (USD/K Doses) and Gross Margin (2018-2023)
    Table 111. Biogenesis Bagó Main Business
    Table 112. Biogenesis Bagó Latest Developments
    Table 113. BIGVET Biotech Basic Information, Foot and Mouth Disease (FMD) Vaccines Manufacturing Base, Sales Area and Its Competitors
    Table 114. BIGVET Biotech Foot and Mouth Disease (FMD) Vaccines Product Portfolios and Specifications
    Table 115. BIGVET Biotech Foot and Mouth Disease (FMD) Vaccines Sales (M Doses), Revenue ($ Million), Price (USD/K Doses) and Gross Margin (2018-2023)
    Table 116. BIGVET Biotech Main Business
    Table 117. BIGVET Biotech Latest Developments
    Table 118. Boehringer Ingelheim Basic Information, Foot and Mouth Disease (FMD) Vaccines Manufacturing Base, Sales Area and Its Competitors
    Table 119. Boehringer Ingelheim Foot and Mouth Disease (FMD) Vaccines Product Portfolios and Specifications
    Table 120. Boehringer Ingelheim Foot and Mouth Disease (FMD) Vaccines Sales (M Doses), Revenue ($ Million), Price (USD/K Doses) and Gross Margin (2018-2023)
    Table 121. Boehringer Ingelheim Main Business
    Table 122. Boehringer Ingelheim Latest Developments
    Table 123. MSD Animal Health Basic Information, Foot and Mouth Disease (FMD) Vaccines Manufacturing Base, Sales Area and Its Competitors
    Table 124. MSD Animal Health Foot and Mouth Disease (FMD) Vaccines Product Portfolios and Specifications
    Table 125. MSD Animal Health Foot and Mouth Disease (FMD) Vaccines Sales (M Doses), Revenue ($ Million), Price (USD/K Doses) and Gross Margin (2018-2023)
    Table 126. MSD Animal Health Main Business
    Table 127. MSD Animal Health Latest Developments
    Table 128. CEVA Basic Information, Foot and Mouth Disease (FMD) Vaccines Manufacturing Base, Sales Area and Its Competitors
    Table 129. CEVA Foot and Mouth Disease (FMD) Vaccines Product Portfolios and Specifications
    Table 130. CEVA Foot and Mouth Disease (FMD) Vaccines Sales (M Doses), Revenue ($ Million), Price (USD/K Doses) and Gross Margin (2018-2023)
    Table 131. CEVA Main Business
    Table 132. CEVA Latest Developments
    Table 133. FGBI Basic Information, Foot and Mouth Disease (FMD) Vaccines Manufacturing Base, Sales Area and Its Competitors
    Table 134. FGBI Foot and Mouth Disease (FMD) Vaccines Product Portfolios and Specifications
    Table 135. FGBI Foot and Mouth Disease (FMD) Vaccines Sales (M Doses), Revenue ($ Million), Price (USD/K Doses) and Gross Margin (2018-2023)
    Table 136. FGBI Main Business
    Table 137. FGBI Latest Developments
    Table 138. Bayer HealthCare Basic Information, Foot and Mouth Disease (FMD) Vaccines Manufacturing Base, Sales Area and Its Competitors
    Table 139. Bayer HealthCare Foot and Mouth Disease (FMD) Vaccines Product Portfolios and Specifications
    Table 140. Bayer HealthCare Foot and Mouth Disease (FMD) Vaccines Sales (M Doses), Revenue ($ Million), Price (USD/K Doses) and Gross Margin (2018-2023)
    Table 141. Bayer HealthCare Main Business
    Table 142. Bayer HealthCare Latest Developments
    Table 143. Brilliant Bio Pharma Basic Information, Foot and Mouth Disease (FMD) Vaccines Manufacturing Base, Sales Area and Its Competitors
    Table 144. Brilliant Bio Pharma Foot and Mouth Disease (FMD) Vaccines Product Portfolios and Specifications
    Table 145. Brilliant Bio Pharma Foot and Mouth Disease (FMD) Vaccines Sales (M Doses), Revenue ($ Million), Price (USD/K Doses) and Gross Margin (2018-2023)
    Table 146. Brilliant Bio Pharma Main Business
    Table 147. Brilliant Bio Pharma Latest Developments
    Table 148. VECOL Basic Information, Foot and Mouth Disease (FMD) Vaccines Manufacturing Base, Sales Area and Its Competitors
    Table 149. VECOL Foot and Mouth Disease (FMD) Vaccines Product Portfolios and Specifications
    Table 150. VECOL Foot and Mouth Disease (FMD) Vaccines Sales (M Doses), Revenue ($ Million), Price (USD/K Doses) and Gross Margin (2018-2023)
    Table 151. VECOL Main Business
    Table 152. VECOL Latest Developments
    Table 153. Sanofi (Merial) Basic Information, Foot and Mouth Disease (FMD) Vaccines Manufacturing Base, Sales Area and Its Competitors
    Table 154. Sanofi (Merial) Foot and Mouth Disease (FMD) Vaccines Product Portfolios and Specifications
    Table 155. Sanofi (Merial) Foot and Mouth Disease (FMD) Vaccines Sales (M Doses), Revenue ($ Million), Price (USD/K Doses) and Gross Margin (2018-2023)
    Table 156. Sanofi (Merial) Main Business
    Table 157. Sanofi (Merial) Latest Developments
    Table 158. VETAL Basic Information, Foot and Mouth Disease (FMD) Vaccines Manufacturing Base, Sales Area and Its Competitors
    Table 159. VETAL Foot and Mouth Disease (FMD) Vaccines Product Portfolios and Specifications
    Table 160. VETAL Foot and Mouth Disease (FMD) Vaccines Sales (M Doses), Revenue ($ Million), Price (USD/K Doses) and Gross Margin (2018-2023)
    Table 161. VETAL Main Business
    Table 162. VETAL Latest Developments
    Table 163. BVI Basic Information, Foot and Mouth Disease (FMD) Vaccines Manufacturing Base, Sales Area and Its Competitors
    Table 164. BVI Foot and Mouth Disease (FMD) Vaccines Product Portfolios and Specifications
    Table 165. BVI Foot and Mouth Disease (FMD) Vaccines Sales (M Doses), Revenue ($ Million), Price (USD/K Doses) and Gross Margin (2018-2023)
    Table 166. BVI Main Business
    Table 167. BVI Latest Developments
    Table 168. LIMOR Basic Information, Foot and Mouth Disease (FMD) Vaccines Manufacturing Base, Sales Area and Its Competitors
    Table 169. LIMOR Foot and Mouth Disease (FMD) Vaccines Product Portfolios and Specifications
    Table 170. LIMOR Foot and Mouth Disease (FMD) Vaccines Sales (M Doses), Revenue ($ Million), Price (USD/K Doses) and Gross Margin (2018-2023)
    Table 171. LIMOR Main Business
    Table 172. LIMOR Latest Developments
    Table 173. ME VAC Basic Information, Foot and Mouth Disease (FMD) Vaccines Manufacturing Base, Sales Area and Its Competitors
    Table 174. ME VAC Foot and Mouth Disease (FMD) Vaccines Product Portfolios and Specifications
    Table 175. ME VAC Foot and Mouth Disease (FMD) Vaccines Sales (M Doses), Revenue ($ Million), Price (USD/K Doses) and Gross Margin (2018-2023)
    Table 176. ME VAC Main Business
    Table 177. ME VAC Latest Developments
    Table 178. Agrovet Basic Information, Foot and Mouth Disease (FMD) Vaccines Manufacturing Base, Sales Area and Its Competitors
    Table 179. Agrovet Foot and Mouth Disease (FMD) Vaccines Product Portfolios and Specifications
    Table 180. Agrovet Foot and Mouth Disease (FMD) Vaccines Sales (M Doses), Revenue ($ Million), Price (USD/K Doses) and Gross Margin (2018-2023)
    Table 181. Agrovet Main Business
    Table 182. Agrovet Latest Developments
List of Figures
    Figure 1. Picture of Foot and Mouth Disease (FMD) Vaccines
    Figure 2. Foot and Mouth Disease (FMD) Vaccines Report Years Considered
    Figure 3. Research Objectives
    Figure 4. Research Methodology
    Figure 5. Research Process and Data Source
    Figure 6. Global Foot and Mouth Disease (FMD) Vaccines Sales Growth Rate 2018-2029 (M Doses)
    Figure 7. Global Foot and Mouth Disease (FMD) Vaccines Revenue Growth Rate 2018-2029 ($ Millions)
    Figure 8. Foot and Mouth Disease (FMD) Vaccines Sales by Region (2018, 2022 & 2029) & ($ Millions)
    Figure 9. Product Picture of Emergency Vaccines
    Figure 10. Product Picture of Conventional Vaccines
    Figure 11. Global Foot and Mouth Disease (FMD) Vaccines Sales Market Share by Type in 2022
    Figure 12. Global Foot and Mouth Disease (FMD) Vaccines Revenue Market Share by Type (2018-2023)
    Figure 13. Foot and Mouth Disease (FMD) Vaccines Consumed in Cattle
    Figure 14. Global Foot and Mouth Disease (FMD) Vaccines Market: Cattle (2018-2023) & (M Doses)
    Figure 15. Foot and Mouth Disease (FMD) Vaccines Consumed in Pig
    Figure 16. Global Foot and Mouth Disease (FMD) Vaccines Market: Pig (2018-2023) & (M Doses)
    Figure 17. Foot and Mouth Disease (FMD) Vaccines Consumed in Sheep and Goat
    Figure 18. Global Foot and Mouth Disease (FMD) Vaccines Market: Sheep and Goat (2018-2023) & (M Doses)
    Figure 19. Foot and Mouth Disease (FMD) Vaccines Consumed in Others
    Figure 20. Global Foot and Mouth Disease (FMD) Vaccines Market: Others (2018-2023) & (M Doses)
    Figure 21. Global Foot and Mouth Disease (FMD) Vaccines Sales Market Share by Application (2022)
    Figure 22. Global Foot and Mouth Disease (FMD) Vaccines Revenue Market Share by Application in 2022
    Figure 23. Foot and Mouth Disease (FMD) Vaccines Sales Market by Company in 2022 (M Doses)
    Figure 24. Global Foot and Mouth Disease (FMD) Vaccines Sales Market Share by Company in 2022
    Figure 25. Foot and Mouth Disease (FMD) Vaccines Revenue Market by Company in 2022 ($ Million)
    Figure 26. Global Foot and Mouth Disease (FMD) Vaccines Revenue Market Share by Company in 2022
    Figure 27. Global Foot and Mouth Disease (FMD) Vaccines Sales Market Share by Geographic Region (2018-2023)
    Figure 28. Global Foot and Mouth Disease (FMD) Vaccines Revenue Market Share by Geographic Region in 2022
    Figure 29. Americas Foot and Mouth Disease (FMD) Vaccines Sales 2018-2023 (M Doses)
    Figure 30. Americas Foot and Mouth Disease (FMD) Vaccines Revenue 2018-2023 ($ Millions)
    Figure 31. APAC Foot and Mouth Disease (FMD) Vaccines Sales 2018-2023 (M Doses)
    Figure 32. APAC Foot and Mouth Disease (FMD) Vaccines Revenue 2018-2023 ($ Millions)
    Figure 33. Europe Foot and Mouth Disease (FMD) Vaccines Sales 2018-2023 (M Doses)
    Figure 34. Europe Foot and Mouth Disease (FMD) Vaccines Revenue 2018-2023 ($ Millions)
    Figure 35. Middle East & Africa Foot and Mouth Disease (FMD) Vaccines Sales 2018-2023 (M Doses)
    Figure 36. Middle East & Africa Foot and Mouth Disease (FMD) Vaccines Revenue 2018-2023 ($ Millions)
    Figure 37. Americas Foot and Mouth Disease (FMD) Vaccines Sales Market Share by Country in 2022
    Figure 38. Americas Foot and Mouth Disease (FMD) Vaccines Revenue Market Share by Country in 2022
    Figure 39. Americas Foot and Mouth Disease (FMD) Vaccines Sales Market Share by Type (2018-2023)
    Figure 40. Americas Foot and Mouth Disease (FMD) Vaccines Sales Market Share by Application (2018-2023)
    Figure 41. United States Foot and Mouth Disease (FMD) Vaccines Revenue Growth 2018-2023 ($ Millions)
    Figure 42. Canada Foot and Mouth Disease (FMD) Vaccines Revenue Growth 2018-2023 ($ Millions)
    Figure 43. Mexico Foot and Mouth Disease (FMD) Vaccines Revenue Growth 2018-2023 ($ Millions)
    Figure 44. Brazil Foot and Mouth Disease (FMD) Vaccines Revenue Growth 2018-2023 ($ Millions)
    Figure 45. APAC Foot and Mouth Disease (FMD) Vaccines Sales Market Share by Region in 2022
    Figure 46. APAC Foot and Mouth Disease (FMD) Vaccines Revenue Market Share by Regions in 2022
    Figure 47. APAC Foot and Mouth Disease (FMD) Vaccines Sales Market Share by Type (2018-2023)
    Figure 48. APAC Foot and Mouth Disease (FMD) Vaccines Sales Market Share by Application (2018-2023)
    Figure 49. China Foot and Mouth Disease (FMD) Vaccines Revenue Growth 2018-2023 ($ Millions)
    Figure 50. Japan Foot and Mouth Disease (FMD) Vaccines Revenue Growth 2018-2023 ($ Millions)
    Figure 51. South Korea Foot and Mouth Disease (FMD) Vaccines Revenue Growth 2018-2023 ($ Millions)
    Figure 52. Southeast Asia Foot and Mouth Disease (FMD) Vaccines Revenue Growth 2018-2023 ($ Millions)
    Figure 53. India Foot and Mouth Disease (FMD) Vaccines Revenue Growth 2018-2023 ($ Millions)
    Figure 54. Australia Foot and Mouth Disease (FMD) Vaccines Revenue Growth 2018-2023 ($ Millions)
    Figure 55. China Taiwan Foot and Mouth Disease (FMD) Vaccines Revenue Growth 2018-2023 ($ Millions)
    Figure 56. Europe Foot and Mouth Disease (FMD) Vaccines Sales Market Share by Country in 2022
    Figure 57. Europe Foot and Mouth Disease (FMD) Vaccines Revenue Market Share by Country in 2022
    Figure 58. Europe Foot and Mouth Disease (FMD) Vaccines Sales Market Share by Type (2018-2023)
    Figure 59. Europe Foot and Mouth Disease (FMD) Vaccines Sales Market Share by Application (2018-2023)
    Figure 60. Germany Foot and Mouth Disease (FMD) Vaccines Revenue Growth 2018-2023 ($ Millions)
    Figure 61. France Foot and Mouth Disease (FMD) Vaccines Revenue Growth 2018-2023 ($ Millions)
    Figure 62. UK Foot and Mouth Disease (FMD) Vaccines Revenue Growth 2018-2023 ($ Millions)
    Figure 63. Italy Foot and Mouth Disease (FMD) Vaccines Revenue Growth 2018-2023 ($ Millions)
    Figure 64. Russia Foot and Mouth Disease (FMD) Vaccines Revenue Growth 2018-2023 ($ Millions)
    Figure 65. Middle East & Africa Foot and Mouth Disease (FMD) Vaccines Sales Market Share by Country in 2022
    Figure 66. Middle East & Africa Foot and Mouth Disease (FMD) Vaccines Revenue Market Share by Country in 2022
    Figure 67. Middle East & Africa Foot and Mouth Disease (FMD) Vaccines Sales Market Share by Type (2018-2023)
    Figure 68. Middle East & Africa Foot and Mouth Disease (FMD) Vaccines Sales Market Share by Application (2018-2023)
    Figure 69. Egypt Foot and Mouth Disease (FMD) Vaccines Revenue Growth 2018-2023 ($ Millions)
    Figure 70. South Africa Foot and Mouth Disease (FMD) Vaccines Revenue Growth 2018-2023 ($ Millions)
    Figure 71. Israel Foot and Mouth Disease (FMD) Vaccines Revenue Growth 2018-2023 ($ Millions)
    Figure 72. Turkey Foot and Mouth Disease (FMD) Vaccines Revenue Growth 2018-2023 ($ Millions)
    Figure 73. GCC Country Foot and Mouth Disease (FMD) Vaccines Revenue Growth 2018-2023 ($ Millions)
    Figure 74. Manufacturing Cost Structure Analysis of Foot and Mouth Disease (FMD) Vaccines in 2022
    Figure 75. Manufacturing Process Analysis of Foot and Mouth Disease (FMD) Vaccines
    Figure 76. Industry Chain Structure of Foot and Mouth Disease (FMD) Vaccines
    Figure 77. Channels of Distribution
    Figure 78. Global Foot and Mouth Disease (FMD) Vaccines Sales Market Forecast by Region (2024-2029)
    Figure 79. Global Foot and Mouth Disease (FMD) Vaccines Revenue Market Share Forecast by Region (2024-2029)
    Figure 80. Global Foot and Mouth Disease (FMD) Vaccines Sales Market Share Forecast by Type (2024-2029)
    Figure 81. Global Foot and Mouth Disease (FMD) Vaccines Revenue Market Share Forecast by Type (2024-2029)
    Figure 82. Global Foot and Mouth Disease (FMD) Vaccines Sales Market Share Forecast by Application (2024-2029)
    Figure 83. Global Foot and Mouth Disease (FMD) Vaccines Revenue Market Share Forecast by Application (2024-2029)

Jinyu Group
Cavet Bio
Indian Immunologicals
Tecon Group
CAHIC
Shen Lian
Biogenesis Bagó
BIGVET Biotech
Boehringer Ingelheim
MSD Animal Health
CEVA
FGBI
Bayer HealthCare
Brilliant Bio Pharma
VECOL
Sanofi (Merial)
VETAL
BVI
LIMOR
ME VAC
Agrovet

LP Information presents a detailed picture of the market by way of study, synthesis, and summation of data from multiple sources. The analysts have presented the various facets of the market with a particular focus on identifying the key industry influencers. The data thus presented is comprehensive, reliable, and the result of extensive research, both primary and secondary.

• Primary Source
  Players/Suppliers
  Industry Experts
  Distributors/Traders
  Opinion Leaders
  Front-line Staff
  Marketing Executives

  Secondary Source
  Journals and Periodicals
  Government Bodies
  Annual Reports
  Presentations
  Paid Databases
  LPI Internal Repository

• Data Synthesis
  Information Gathering
  Collation of Data
  Estimation of Key Figures
  Analysis of Derived Insights

  Data Validation
  Triangulation with Data Models
  Reference Against Proprietary
  Databases
  Corroboration with Industry Experts

• Qualitative Analysis
  Market drivers
  Market challenges
  Market trends
  Five forces analysis

  Qualitative Analysis
  Market size and forecast
  Market segmentation
  Geographical insights
  Competitive landscape